Notice Number: NOT-HD-06-001
Release Date: December 2, 2005
National Institute of Child Health and Human Development (NICHD), (http://www.nichd.nih.gov/)
This Notice is to inform the scientific community of amendments to RFA-HD-05-019, “Pelvic Floor Disorders Network” originally issue on August 17, 2005 (http://grants.nih.gov/grants/guide/rfa-files/RFA-HD-05-019.html). Specifically, this Notice:
All other requirements outlined in the RFA remain unchanged.
Allowable Costs for Clinical Sites
The earlier guidance stated that: “An applicant for a Clinical Site may request a project period for up to 5 years and a budget for direct costs associated with base costs up to $125,000 per year.” This amount is changed from $125,000 to $175,000 (direct costs).
This change affects the language in the Executive Summary (3 rd bullet); the section on Funds Available (Section II.2. Award Information, Funds Available); and the 5th paragraph under Budget Preparation: Clinical Site Applicants in the Other Submission Requirements section of RFA-HD-05-019 (Section IV.6. Application and Submission Information, Other Submission Requirements, Clinical Site Applications, Budget Preparation: Clinical Site Applicants).
Qualifications for Principal Investigator and Clinical Investigators
The earlier guidance stated that: “The Principal Investigator for a Clinical Site should be a practicing clinical urogynecologist in the field of female pelvic floor disorders who is able to make a substantive long-term commitment of effort to Network responsibilities.”
This language is modified, as follows: “The Principal Investigator should be able to make a substantive long-term commitment of effort to Network responsibilities. The clinical investigators at each Clinical Site must include a urogynecologist and a urologist with demonstrated training and experience in the diagnosis and treatment of pelvic floor disorders in women. It is expected that either a urologist or a urogynecologist will serve as the Principal Investigator for a Clinical Site.”
This change affects the language in the Eligible Individuals section (Section III.1.B. Eligibility Information, Eligible Applicants, Eligible Individuals); the 2 nd bullet under the Minimum Requirements: Clinical Site in the Other Submission Requirements section (Section IV.6. Application and Submission Information, Other Submission Requirements, Clinical Site Applications, Minimum Requirements: Clinical Site); and the 1 st paragraph under Clinician-Investigators in Female Pelvic Floor Disorders: Clinical Site in the Other Submission Requirements section (Section IV.6. Application and Submission Information, Other Submission Requirements, Clinical Site Applications, Clinician-Investigators in Female Pelvic Floor Disorders: Clinical Site)
For further information, contact:
Anne M. Weber, M.D., M.S.
Contraception and Reproductive Health Branch
National Institute of Child Health and Human Development
6100 Executive Boulevard , Room 8B-13C, MSC 7510
Bethesda , MD 20892-7510
(Rockville , MD 20852 for express/courier service, non-US Postal Service)
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.